Invention Grant
- Patent Title: Sustained release dosage forms for a JAK1 inhibitor
-
Application No.: US15599084Application Date: 2017-05-18
-
Publication No.: US10561616B2Publication Date: 2020-02-18
- Inventor: Krishnaswamy Yeleswaram , Bhavnish Parikh , Dilip P. Modi , Trupti Sheth
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K9/20
Abstract:
This invention relates to sustained release dosage forms comprising {1-{1-[3-fluoro-2-(trifluoromethyl)isonicotinoyl]piperidin-4-yl}-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile, or a pharmaceutically acceptable salt thereof, and doses and methods related thereto.
Public/Granted literature
- US20170319487A1 SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR Public/Granted day:2017-11-09
Information query
IPC分类:
